More on RANI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Rani Therapeutics (NQ:RANI)
Delayed: 1.30 -0.04 (2.99%)
Prev. Close $1.34  
Open$1.32 
52 Wk High$ 
52 Wk Low$ 
Day High$1.34 
Day Low$1.28 
P/E N/A  
EPS$ 
Volume733,116 


Feb 13, 2026 12:31 PM Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: AWM Investment Company, Inc.
Feb 12, 2026 01:45 PM Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: SymBiosis Capital Partners, LLC
Jan 30, 2026 02:44 PM Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: VANGUARD GROUP INC
Jan 28, 2026 07:01 AM Rani Therapeutics promotes Alireza Javadi to chief technical officer
Jan 28, 2026 07:00 AM Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
Jan 8, 2026 07:00 AM Rani Therapeutics starts phase 1 obesity trial with oral drug capsule
Jan 8, 2026 07:00 AM Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen
Jan 2, 2026 05:27 PM Form 8-K Rani Therapeutics Holdin For: Dec 31
Dec 5, 2025 04:06 PM Form DEF 14C Rani Therapeutics Holdin For: Dec 05
Dec 4, 2025 06:04 AM Form EFFECT Rani Therapeutics Holdin
View All Articles

Entities mentioned with RANI

View All Entities